BIO-RAD LABORATORIES, INC. - CL A (BIO)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / CL A
Shares, excl. options Q1 2024
17.7 M
Holdings value Q1 2024
$6.11 B
Value change Q1 2024
-$143 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
443
Number of buys Q1 2024
209
Number of sells Q1 2024
-220
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.003%
CUSIP
090572207
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 17.7 M $6.11 B -$143 M $345.87 443
2023 Q4 18.2 M $5.86 B -$38 M $322.89 463
2023 Q3 18.4 M $6.61 B -$70.2 M $358.45 454
2023 Q2 17.8 M $6.75 B -$278 M $379.12 450
2023 Q1 19 M $9.09 B +$18.9 M $479.02 486
2022 Q4 19 M $8 B -$128 M $420.49 457
2022 Q3 19.4 M $8.08 B +$130 M $417.14 459
2022 Q2 19 M $9.4 B +$17.4 M $495.00 479
2022 Q1 19 M $10.7 B -$18.7 M $563.23 493
2021 Q4 18.9 M $14.3 B -$402 M $755.57 506
2021 Q3 18.9 M $14.1 B -$123 M $745.95 490
2021 Q2 17.7 M $11.4 B -$227 M $644.29 493
2021 Q1 19.5 M $11.1 B -$15.4 M $571.17 475
2020 Q4 19.6 M $11.4 B +$294 M $582.94 474
2020 Q3 18.8 M $9.7 B +$5.82 M $515.46 465
2020 Q2 19.2 M $8.65 B +$190 M $451.49 455
2020 Q1 18.7 M $6.56 B -$7.55 M $350.56 388
2019 Q4 18.9 M $6.98 B -$71.2 M $370.03 374
2019 Q3 19.1 M $6.35 B +$145 M $332.74 342
2019 Q2 18.6 M $5.82 B -$97.2 M $312.59 322
2019 Q1 19.3 M $5.9 B +$30.2 M $305.68 337
2018 Q4 18.5 M $4.29 B -$58.6 M $232.22 314
2018 Q3 18.9 M $5.91 B +$12.4 M $312.99 331
2018 Q2 19.1 M $5.5 B -$8.92 M $288.54 315
2018 Q1 19.3 M $4.81 B +$32 M $250.08 304
2017 Q4 19.2 M $4.58 B +$6.46 M $238.67 294
2017 Q3 19.2 M $4.26 B +$85 M $222.22 269
2017 Q2 18.8 M $4.26 B -$43.9 M $226.31 274
2017 Q1 19 M $3.8 B +$211 M $199.34 267
2016 Q4 19.7 M $3.58 B +$100 M $182.28 249
2016 Q3 19.1 M $3.12 B +$559 K $163.81 231
2016 Q2 18.8 M $2.69 B +$67.6 M $143.02 227
2016 Q1 18.3 M $2.5 B -$30.8 M $136.72 223
2015 Q4 18.3 M $2.53 B -$10.8 M $138.66 232
2015 Q3 18.7 M $2.51 B +$20.7 M $134.31 238
2015 Q2 18.4 M $2.78 B -$14 M $150.61 219
2015 Q1 18.8 M $2.55 B +$11.1 M $135.18 212
2014 Q4 18.8 M $2.27 B +$17.4 M $120.56 210
2014 Q3 18.4 M $2.09 B +$35.4 M $113.40 198
2014 Q2 18.3 M $2.19 B +$17.3 M $119.71 201
2014 Q1 18.1 M $2.31 B -$21.5 M $128.12 188